{
    "qa_pairs": {
        "What advantage do nanobodies have over traditional antibodies in targeting the spike protein of SARS-CoV-2?": [
        ],
        "What is the primary target of the engineered nanobodies discussed in the study?": [
        ],
        "What mechanism allows multivalent nanobodies to enhance neutralization efficacy against SARS-CoV-2 variants?": [
        ],
        "What was the geometric mean IC50 of the most potent multivalent nanobody, B13-B13-B13, against all tested pseudoviruses?": [
        ],
        "Which nanobody demonstrated broad-spectrum neutralization against multiple Omicron subvariants including BQ.1.1 and XBB.1?": [
        ]
    }
}